Literature DB >> 12679321

Tracheal occlusion stimulates cell cycle progression and type I cell differentiation in lungs of fetal rats.

Jyoji Yoshizawa1, Cheryl J Chapin, Lourenco Sbragia, Robert Ertsey, Jorge A Gutierrez, Craig T Albanese, Joseph A Kitterman.   

Abstract

Fetal tracheal occlusion (TO) has been reported to stimulate lung growth but decreases number and maturation of type II cells, effects that vary with gestational age and duration of TO. We examined effects of a novel method of TO (unipolar microcautery to seal the trachea) produced at 19.5-20 days (d) of gestation in fetal rats; fetuses were delivered at term, 22 d. Controls were sham operated and unoperated littermates. TO increased wet lung weight but not dry lung weight or lung DNA and protein. To evaluate further the effects of TO, we examined the cell cycle regulators, cyclins D1 and A, in fetal lungs. Cyclin D1 increased with TO (P < 0.005). TO also increased expression of the type I epithelial cell marker RTI40 (mRNA and protein). TO decreased mRNA for surfactant proteins (SP)-A and -C but did not affect protein levels of SP-A and -B and of RTII70, a type II epithelial cell marker. We conclude that TO by microcautery, even of short duration, has diverse pulmonary effects including stimulating increased levels of cyclin D1 with probable cell cycle progression, type I cell differentiation, and possibly inhibiting type II cell function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679321     DOI: 10.1152/ajplung.00281.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  Proteomic profiling of tracheal fluid in an ovine model of congenital diaphragmatic hernia and fetal tracheal occlusion.

Authors:  Jose Luis Peiro; Marc Oria; Emrah Aydin; Rashika Joshi; Nichole Cabanas; Ronny Schmidt; Christoph Schroeder; Mario Marotta; Brian M Varisco
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

2.  The Rho pathway mediates transition to an alveolar type I cell phenotype during static stretch of alveolar type II cells.

Authors:  Cherie D Foster; Linda S Varghese; Linda W Gonzales; Susan S Margulies; Susan H Guttentag
Journal:  Pediatr Res       Date:  2010-06       Impact factor: 3.756

3.  Fetal tracheal occlusion for the treatment of congenital diaphragmatic hernia.

Authors:  Jean-Martin Laberge; Hélène Flageole
Journal:  World J Surg       Date:  2007-05-18       Impact factor: 3.352

4.  Maternal administration of betamethasone inhibits proliferation induced by fetal tracheal occlusion in the nitrofen rat model for congenital diaphragmatic hernia: a placebo-controlled study.

Authors:  Steffi Mayer; Philipp Klaritsch; Lourenço Sbragia; Jaan Toelen; Holger Till; Jan A Deprest
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

5.  Evaluation of histological changes after tracheal occlusion at different gestational ages in a fetal rat model.

Authors:  Rodrigo Melo Gallindo; Frances Lilian Lanhellas Gonçalves; Carolina Teixeira de Resende Barreto; Augusto Frederico Santos Schmidt; Luis Antonio Violin Dias Pereira; Lourenço Sbragia
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

6.  Alveolarization genes modulated by fetal tracheal occlusion in the rabbit model for congenital diaphragmatic hernia: a randomized study.

Authors:  Aline Vuckovic; Susanne Herber-Jonat; Andreas W Flemmer; Xenia I Roubliova; Jacques C Jani
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.